Sign In to Follow Application
View All Documents & Correspondence

Therapeutic Uses Of Dulaglutide

Abstract: The present invention relates to methods for treating, preventing or delaying disorders relating to cognition, such as cognitive decline, cognitive impairment or dementia in a patient. Specifically, the method comprising administering dulaglutide in a therapeutically effective amount to the patient once weekly. Further disclosed are methods for improving glycemic control in a patient with type 2 diabetes mellitus, comprising administering dulaglutide in a therapeutically effective amount for reducing the risk of the patient experiencing cognitive decline.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
23 August 2022
Publication Number
03/2024
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

ELI LILLY AND COMPANY
Lilly Corporate Center Indianapolis, Indiana 46206-6288

Inventors

1. GERSTEIN, Hertzel Chaim
c/o Eli Lilly and Company P.O. Box 6288 Indianapolis, Indiana 46206-6288

Specification

Documents

Application Documents

# Name Date
1 202217047874.pdf 2022-08-23
2 202217047874-STATEMENT OF UNDERTAKING (FORM 3) [23-08-2022(online)].pdf 2022-08-23
3 202217047874-Sequence Listing in txt [23-08-2022(online)].txt 2022-08-23
4 202217047874-Sequence Listing in PDF [23-08-2022(online)].pdf 2022-08-23
5 202217047874-REQUEST FOR EXAMINATION (FORM-18) [23-08-2022(online)].pdf 2022-08-23
6 202217047874-FORM 18 [23-08-2022(online)].pdf 2022-08-23
7 202217047874-FORM 1 [23-08-2022(online)].pdf 2022-08-23
8 202217047874-DECLARATION OF INVENTORSHIP (FORM 5) [23-08-2022(online)].pdf 2022-08-23
9 202217047874-COMPLETE SPECIFICATION [23-08-2022(online)].pdf 2022-08-23
10 202217047874-FORM-26 [24-08-2022(online)].pdf 2022-08-24
11 202217047874-FORM-26 [26-08-2022(online)].pdf 2022-08-26
12 202217047874-RELEVANT DOCUMENTS [02-09-2022(online)].pdf 2022-09-02
13 202217047874-MARKED COPIES OF AMENDEMENTS [02-09-2022(online)].pdf 2022-09-02
14 202217047874-Information under section 8(2) [02-09-2022(online)].pdf 2022-09-02
15 202217047874-FORM 13 [02-09-2022(online)].pdf 2022-09-02
16 202217047874-AMMENDED DOCUMENTS [02-09-2022(online)].pdf 2022-09-02
17 202217047874-Proof of Right [16-09-2022(online)].pdf 2022-09-16
18 202217047874-FORM 3 [24-01-2023(online)].pdf 2023-01-24
19 202217047874-FER.pdf 2025-11-10

Search Strategy

1 202217047874_SearchStrategyNew_E_A11E_18-09-2025.pdf